The estimated Net Worth of Robert E. Waltermire is at least $1.96 Milion dollars as of 14 June 2024. Dr Waltermire owns over 1,900 units of Madrigal Pharmaceuticals Inc stock worth over $1,724,200 and over the last 3 years he sold MDGL stock worth over $239,668.
Dr has made over 6 trades of the Madrigal Pharmaceuticals Inc stock since 2023, according to the Form 4 filled with the SEC. Most recently he exercised 1,900 units of MDGL stock worth $165,471 on 14 June 2024.
The largest trade he's ever made was exercising 10,000 units of Madrigal Pharmaceuticals Inc stock on 28 February 2023 worth over $879,200. On average, Dr trades about 2,067 units every 43 days since 2021. As of 14 June 2024 he still owns at least 7,400 units of Madrigal Pharmaceuticals Inc stock.
You can see the complete history of Dr Waltermire stock trades at the bottom of the page.
Dr. Robert E. Waltermire Ph.D. is the Chief Pharmaceutical Devel. Officer at Madrigal Pharmaceuticals Inc.
Dr D is 57, he's been the Chief Pharmaceutical Devel. Officer of Madrigal Pharmaceuticals Inc since . There are 13 older and 4 younger executives at Madrigal Pharmaceuticals Inc. The oldest executive at Madrigal Pharmaceuticals Inc is David Milligan, 79, who is the Independent Director.
Robert's mailing address filed with the SEC is C/O MADRIGAL PHARMACEUTICALS, INC., 200 BARR HARBOR DRIVE, SUITE 200, WEST CONSHOHOCKEN, PA, 19428.
Over the last 8 years, insiders at Madrigal Pharmaceuticals Inc have traded over $471,222,585 worth of Madrigal Pharmaceuticals Inc stock and bought 443,785 units worth $79,114,183 . The most active insiders traders include Bros. Advisors Lp667, L.P.B..., Paul A Friedman oraz Bros. Advisors Lp667, L.P.B.... On average, Madrigal Pharmaceuticals Inc executives and independent directors trade stock every 56 days with the average trade being worth of $20,602,093. The most recent stock trade was executed by William John Sibold on 9 September 2024, trading 6,363 units of MDGL stock currently worth $1,551,490.
madrigal pharmaceuticals inc. is a biotechnology company based out of calle laguna del marquesado nª 19, nave 16 edificio adriana 1ª planta, polígono industrial la resina (villaverde), madrid, community of madrid, spain.
Madrigal Pharmaceuticals Inc executives and other stock owners filed with the SEC include: